Back to the main directory
Company Update / Equity
- Hoshizaki (6465 JP) (Buy) 18/12 results: release delayed, as in Q3 by Nomura Research
- Renesas Electronics (6723 JP) (Buy) Earnings update by Nomura Research
- NTTドコモ (9437 JP) (Buy) ä¸æœŸåˆ©ç›Šå›žå¾©ã‚’å‰æã«æ ªä¸»é‚„å…ƒåŠ é€Ÿã«æ³¨ç›® (ADR:DCM US) by Nomura Research
- XL Axiata (EXCL IJ, Buy) - Good results and outlook by Nomura Research
- カプコン (9697 JP) (Neutral) 開発力å‘上ã€ã‚³ãƒ³ã‚·ãƒ¥ãƒ¼ãƒžãƒ¼äº‹æ¥ã¯å¥½èª¿ã‚’ç¶æŒ by Nomura Research
- NetEase (NTES US, Buy) - Reportedly to merge the CBE of Amazon China by Nomura Research
- ãƒãƒƒãƒˆã‚¤ãƒ¼ã‚º(Buy)アマゾンä¸å›½ã®è¶Šå¢ƒECã¨ã®åˆä½µå ±é“ã«ã¤ã„㦠by Nomura Research
- Daikin Industries (6367 JP) (Buy) Strong profit potential despite tough conditions by Nomura Research
- WOOD Flash – Polish gencos: 2023E capacity auction by Wood and Company
- ヘリオス (4593 JP) (Buy) パイプライン増・å†ç”ŸåŒ»ç™‚プラットフォーマー㸠by Nomura Research
- Healios (4593 JP) (Buy) Evolving into regenerative medicine platformer by Nomura Research
- Hanwha Aerospace (012450 KS, Buy) - 4Q18 OP in line, NP beat; reiterate Buy by Nomura Research
- Quick Note - Oil and Natural Gas (ONGC IN, Neutral) - 3Q beat, but outlook still unexciting by Nomura Research
- WOOD Flash – KAZ Minerals: 2H18 financial results - broadly in line with consensus but higher capex in 2019E by Wood and Company
- Norwegian Cruise Line Holdings Ltd. - Incremental Positives by Nomura Instinet Research
- Omron (6645 JP) (Neutral) 20/3-21/3: harvesting seeds sown with current plan by Nomura Research
- WOOD Flash – Polish banks: BFG charges hiked - the first risk to 2019E banks’ earnings materialises by Wood and Company
- Zee Entertainment Enterprises (Z IN, Buy) - Case for a strategic buyer strong (Erratum) by Nomura Research
- Globe Telecom (GLO PM, Neutral) - Strong trends; but third entrant a concern by Nomura Research
- Intage Holdings (4326 JP) (Neutral) Awaiting new policies under new president by Nomura Research
- Interface, Inc. - One-Time Expense Drags on 1Q by Nomura Instinet Research
- Dropbox, Inc. - 4Q18 Earnings Recap by Nomura Instinet Research
- BioMarin Pharmaceutical Inc. - 4Q18 Results – Risk in PKU Shift by Nomura Instinet Research
- OSJBホールディングス (5912 JP) (Buy) PC床版å–替工事ã®è¦‹å¦ä¼šã‚’開催 by Nomura Research
- æ—¥æœ¬é€šé‹ (9062 JP) (Buy) æ–°ä¸æœŸè¨ˆç”»ã¯äººäº‹åˆ¶åº¦ã‚’変更ã—飛èºã‚’目指㙠by Nomura Research